[1] M. Wang et al.,.(2018).“Age at natural menopause and risk of diabetes in adult women: Findings from the China Kadoorie Biobank study in the Zhejiang area,” J. Diabetes Investig., vol. 9, no. 4, pp. 762–768, , doi: 10.1111/jdi.12775.
[2] Z. Xing, R. S. Kirby, and A. C. Alman,.( 2022).“Association of age at menopause with type 2 diabetes mellitus in postmenopausal women in the United States: National Health and Nutrition Examination Survey 2011–2018,” Prz. Menopauzalny, vol. 21, no. 4, pp. 229–235, doi: 10.5114/pm.2022.123514.
[3] G. A. Georgiopoulos et al.,.(2009).“Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors,” Hypertension, vol. 54, no. 1, pp. 98–105,doi: 10.1161/HYPERTENSIONAHA.109.132100.
[4] A. Monterrosa-Castro et al.,.( 2013).“Type II diabetes mellitus and menopause: A multinational study,” Climacteric, vol. 16, no. 6, pp. 663–672, doi: 10.3109/13697137.2013.798272.
[5] A. Nanri, T. Mizoue, M. Noda, A. Goto, N. Sawada, and S. Tsugane,.(2019).“Menstrual and reproductive factors and type 2 diabetes risk: The Japan Public Health Center-based Prospective Study,” J. Diabetes Investig., vol. 10, no. 1, pp. 147–153, doi: 10.1111/jdi.12853.
[6] M. Wang et al.,.(2022).“Menopausal status, age at natural menopause and risk of diabetes in China: a 10-year prospective study of 300,000 women,” Nutr. Metab., vol. 19, no. 1, pp. 1–12, doi: 10.1186/s12986-022-00643-x.
[7] T. Lathia and S. Kalra,.(2020).“The Interrelationship of Menopause and Type 2 Diabetes Mellitus,” Diabetes Res. – Open J., vol. 6, no. 1, pp. 20–26, doi: 10.17140/droj-6-146.
[8] G. K. and S. N. Sheoran A , Agarwal N , Mahto S K, Gupta P K,.( 2023).“Study of Association of Serum Prolactin Levels with Insulin Resistance in Type 2 Diabetes Mellitus Patients,” Indian J. Endocrinol. Metab., pp. 1–6, doi: 10.4103/ijem.ijem.
[9] A. Amirzadegan, E. Salimi, and A. Hosseinsabet,.(2019).“Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study,” Turk Kardiyol. Dern. Ars., vol. 47, no. 3, pp. 177–184, doi: 10.5543/tkda.2018.45213.
[10] Y. Zhang and H. Liu,.(2022).“Cross-sectional association between prolactin levels and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a retrospective analysis of patients from a single hospital in China,” BMJ Open, vol. 12, no. 10, pp. 1–8, doi: 10.1136/bmjopen-2022-062252.
[11] L. Faria de Castro, Á. Alves dos Santos, L. Augusto Casulari, L. Ansaneli Naves, and A. Amorim Amato,.( 2020).“Association between variations of physiological prolactin serum levels and the risk of type 2 diabetes: A systematic review and meta-analysis,” Diabetes Res. Clin. Pract., vol. 166, doi: 10.1016/j.diabres.2020.108247.
[12] M. Daimon et al.,.(2017).“Association between serum prolactin levels and insulin resistance in non-diabetic men,” PLoS One, vol. 12, no. 4, pp. 5–7, doi: 10.1371/journal.pone.0175204.
[13] J. Chen, G. Liu, Q. Li, and W. Deng,. (2022). “Prolactin is associated with bone mineral density in subjects with type 2 diabetes mellitus,” Front. Endocrinol. (Lausanne)., vol. 13, no. October, pp. 1–10, doi: 10.3389 /fendo. 2022. 964808.
[14] R. M. Ibrahim et al.,.(2014).“A randomised controlled trial on hypolipidemic effects of Nigella Sativa seeds powder in menopausal women,” J. Transl. Med., vol. 12, no. 1, pp. 1–7, doi: 10.1186/1479-5876-12-82.
[15] V. Inaraja, I. Thuissard, C. Andreu-Vazquez, and E. Jodar,.(2020).“Lipid profile changes during the menopausal transition,” Menopause, vol. 27, no. 7, pp. 780–787, doi: 10.1097/ GME. 0000000000001532.
[16] P. Anagnostis et al.,.(2020).“Menopause symptom management in women with dyslipidemias: An EMAS clinical guide,” Maturitas, vol. 135, pp. 82–88, doi: 10.1016/j.maturitas.2020.03.007.
[17] M. I. H. Fonseca, I. T. Da Silva, and S. R. G. Ferreira,.(2017). “Impact of menopause and diabetes on atherogenic lipid profile: Is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?,” Diabetol. Metab. Syndr., vol. 9, no. 1, pp. 1–13, doi: 10.1186/s13098-017-0221-5.
[18] R. Zuhair and B. Hameed,.(2015).“Prolactin is a Novel Biochemical Marker in Sera of Iraqi Type-2 Diabetic Women With Metabolic Syndrome in Baghdad . Prolactin is a Novel Biochemical Marker in Sera of Iraqi Type-2 Diabetic Women With Metabolic Syndrome in Baghdad .,” no. January,.
[19] Hussein S Z and Alsamarrai A H,.(2017).“Hormonal Disturbance in Normal and Diabetic Postmenopausal Women,” Tikrit Med. J., vol. 1, no. 1, pp. 10–15.
[20] Ajam W H. Al-Khyat T H and Al-Hamdani K j, .(2012).“Oxidative Status and Lipid Profile in Post-Menopausal Women with Diabetes Mellitus (DM) Type 2 in Babylon Governorate,” Med. J. Babylon, vol. 9, no. 2, pp. 338–348.
[21] A. M. Hadi, J. H. Yenzeel, and E. N. Salman,.(2018). “Study the effect of Type 2 diabetes melitus on level of reproductive hormones in a sample of Iraqi women,” Int. J. Sci. Nat., vol. 9, no. 1, pp. 90–3.
[22] R. Haring et al., “Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality,.(2014).” Eur. Heart J., vol. 35, no. 18, pp. 1215–1221, doi: 10.1093/eurheartj/ehs233.
[23] Y. Shen et al.,.(2023).“Association of prolactin with all-cause and cardiovascular mortality among patients with type 2 diabetes: a real-world study,” Eur. J. Prev. Cardiol., pp. 1–9, doi: 10.1093/eurjpc/zwad112.
[24] N. Santoro et al.,.(2008). “Factors related to declining luteal function in women during the menopausal transition,” J. Clin. Endocrinol. Metab., vol. 93, no. 5, pp. 1711–1721, doi: 10.1210/jc.2007-2165.
[25] D. Raczkiewicz, A. Owoc, A. Wierzbińska-Stępniak, and I. Bojar,.(2018). “Metabolic syndrome in peri-and postmenopausal women performing intellectual work,” Ann. Agric. Environ. Med., vol. 25, no. 4, pp. 610–615,, doi: 10.26444/aaem/74451.
[26] A. Maduka Ignatius, C. and Nnamdi Ngozika,.(2018). “Original Research Article Open Access Serum Lipids and Glycated Haemoglobin Levels in Pre-and Post Menopausal Diabetic Subjects in Enugu Nigeria.,” Int. J. Dev. Res., vol. 08, no. Cvd, pp. 23949–23954.
[27] E. Ikekpeazu, E. Neboh, I. Maduka, F. Ejezie, and S. Ufelle,.(2009). “Menopausal syndrome: Effect on serum lipid and lipoprotein profiles,” Biomed. Res. - India, vol. 20, no. 3, p. 208,doi: 10.4103/0970-938x.54859.
[28] A. R. V., M. S. A. Khan, S. M., and J. S.,.( 2020). “A Comparative Study of Lipid Profile in Pre- and Post-Menopausal Women with and without Diabetes,” Int. J. Biotechnol. Biochem., vol. 16, no. 2, p. 83, doi: 10.37622/ijbb/16.2.2020.83-91.
[29] A. F. Kadhuim,.(2020). “Estimation of serum lipid profile among pre and post-menopausal women in baghdad city,” Medico-Legal Updat., vol. 20, no. 1, pp. 877–881, doi: 10.37506/v20/il/2020/mlu/194706.
[30] D. K. Song, Y. S. Hong, Y. A. Sung, and H. Lee,.(2023). “The effect of menopause on cardiovascular risk factors according to body mass index in middle-aged Korean women,” PLoS One, vol. 18, no. 3 March, pp. 1–10, doi: 10.1371/journal.pone.0283393.
[31] A. M. A. and A. B. M. Nema R S,.(2009). “Serum Lipid Profile In Type 2 Diabetes Mellitus In Male and Females : More Atherogenic Lipid Profile In Postmenopausal females .,” vol. 14, no.1,pp. 14–22.
[32] S. H. Ko and H. S. Kim,.(2020). “Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women,” Nutrients, vol. 12, no. 1, doi: 10.3390/nu12010202.
[33] M. D. Kulkarni and K. F. Kammar,.(2014). “Lipid Profile in Postmenopausal women of Hubli city,” J Pub Heal. Med Res, vol. 2, no. 1, pp. 25–28.
[34] S. Antwi-Baffour, R. Kyeremeh, S. O. Boateng, L. Annison, and M. A. Seidu,.(2018). “Haematological parameters and lipid profile abnormalities among patients with Type-2 diabetes mellitus in Ghana,” Lipids Health Dis., vol. 17, no. 1, pp. 1–9, doi: 10.1186/s12944-018-0926-y.
[35] S. S. Shende, M. V. Bimanpalli, I. C. Apte, V. V. Mahajan, and H. P. Narkhede,.(2011). “Study of lipid profile and C reactive protein in pre- and post-menopausal women,” J. Clin. Diagnostic Res., vol. 5, no. 8, pp. 1544–1547.
[36] C. J. Kim, T. H. Kim, W. S. Ryu, and U. H. Ryoo,.(2000). “Influence of menopause on high density lipoprotein-cholesterol and lipids,” Journal of Korean Medical Science, vol. 15, no. 4. pp. 380–386, doi: 10.3346/jkms.2000.15.4.380.